reports
- Jonathan Moreland
NKTR NEKTAR THERAPEUTICS
MYE MYERS INDUSTRIES INC.
MERC MERCER INTERNATIONAL INC.
MCHX MARCHEX INC. CL B
GHL GREENHILL & CO. INC.
CUTR CUTERA INC.
COMM COMMSCOPE HOLDING CO. INC.
CLR CONTINENTAL RESOURCES INC.
CALA CALITHERA BIOSCIENCES INC.
ACIW ACI WORLDWIDE INC.
ACGL ARCH CAPITAL GROUP LTD.
AAT AMERICAN ASSETS TRUST INC.
ASUR ASURE SOFTWARE INC
BBBY BED BATH & BEYOND INC.
MGI MONEYGRAM INTERNATIONAL INC.
PBFX PBF LOGISTICS LP
SWM SCHWEITZER-MAUDUIT INTERNATIONAL INC.
HRB H&R BLOCK INC.
VSTO VISTA OUTDOOR INC
SSY SUNLINK HEALTH SYSTEMS
NTIC NORTHERN TECHNOLOGIES INTERNATIONAL
BWFG BANKWELL FINANCIAL GROUP
TRHC TABULA RASA HEALTHCARE
ATGE ADTALEM GLOBAL EDUCATION INC.
DMLP DORCHESTER MINERALS L.P.
BHVN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
MBIO MUSTANG BIO
RCII RENT-A-CENTER INC
COLD AMERICOLD REALTY TRUST
NICK NICHOLAS FINANCIAL INC.
LQDA LIQUIDIA CORPORATION
EVER EVERQUOTE
FTDR FRONTDOOR INC.
FSK FS KKR CAPITAL CORP
VIAC VIACOMCBS INC. CLASS B
IHRT IHEARTMEDIA INC. CLASS A
STTK SHATTUCK LABS
MGNI MAGNITE INC
BALY BALLYS CORPORATION
RPTX REPARE THERAPEUTICS
SKLZ SKILLZ INC (A)
CSU CAPITAL SENIOR LIVING
CMPX COMPASS THERAPEUTICS
LDI INC.
BVH LOANDEPOT
RRD BLUEGREEN VACATIONS HOLDING CORPORATION (A)
BGSF R.R. DONNELLEY & SONS COMPANY
CRYM BG STAFFING INC.
XERS CRYOMASS TECHNOLOGIES
INC.
XERIS BIOPHARMA HLDGS INC
- Jonathan Moreland
NRIM NORTHRIM BANCORP INC.
MCHX MARCHEX INC. CL B
GHL GREENHILL & CO. INC.
CLR CONTINENTAL RESOURCES INC.
ARDX ARDELYX INC
ACGL ARCH CAPITAL GROUP LTD.
ASUR ASURE SOFTWARE INC
MGI MONEYGRAM INTERNATIONAL INC.
PBFX PBF LOGISTICS LP
SWM SCHWEITZER-MAUDUIT INTERNATIONAL INC.
VSTO VISTA OUTDOOR INC
SSY SUNLINK HEALTH SYSTEMS
NTIC NORTHERN TECHNOLOGIES INTERNATIONAL
TRHC TABULA RASA HEALTHCARE
EVRG EVERGY
NICK INC.
LQDA NICHOLAS FINANCIAL INC.
EVER LIQUIDIA CORPORATION
STSA EVERQUOTE
VOXX SATSUMA PHARMACEUTICALS
STTK AUDIOVOX CORPORATION
VLDR SHATTUCK LABS
BVH VELODYNE LIDAR INC
FSBC BLUEGREEN VACATIONS HOLDING CORPORATION (A)
EFTR FIVE STAR BANCORP
BGSF EFFECTOR THERAPEUTICS INC
CRYM BG STAFFING INC.
XERS CRYOMASS TECHNOLOGIES
INC.
XERIS BIOPHARMA HLDGS INC
Sunlink Health Systems Inc: 1 director
A director at Sunlink Health Systems Inc sold/sold after exercising options 100,000 shares at 2.860USD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's ...
SunLink Health Systems, Inc. Announces Fiscal 2017 Third Quarter Resul...
ATLANTA--(BUSINESS WIRE)-- SunLink Health Systems, Inc. (NYSE MKT: SSY) today announced a loss from continuing operations of $890,000 or a loss of $0.10 per fully diluted share for its third fiscal quarter ended March 31, 2017 compared to a loss from continuing operations of $1,392,000, or a loss of $0.15 per fully diluted share, for the quarter ended March 31, 2016. Net earnings for the quarter ended March 31, 2017 were a net loss of $1,025,000 or a loss of $0.11 per fully diluted share compared to a net loss of $1,835,000 or a loss ...
SunLink Health Systems, Inc. Announces Final Results for Tender Offer
ATLANTA--(BUSINESS WIRE)-- SunLink Health Systems, Inc. (NYSE MKT: SSY) today announced the final results of its tender offer (the “Offer”) which expired at 5:00 P.M., New York City Time, on February 24, 2017. The final results were unchanged from the preliminary results announced on February 27, 2017. In the Offer, SunLink offered to purchase up to 3,000,000 of its common shares at a price of $1.50 per share. Based on the final count by American Stock Transfer & Trust Company, the depositary for the tender offer, 280,558 com...
SunLink Health Systems, Inc. Announces Preliminary Results for Tender ...
ATLANTA--(BUSINESS WIRE)-- SunLink Health Systems, Inc. (NYSE MKT: SSY) today announced the preliminary results of its tender offer (the “Offer”) which expired at 5:00 P.M., New York City Time, on February 24, 2017. In the Offer, SunLink offered to purchase up to 3,000,000 of its common shares at a price of $1.50 per share. Based on the preliminary count by American Stock Transfer & Trust Company, the depositary for the tender offer, approximately 280,558 common shares of SunLink were properly tendered and not withdrawn, ...
SunLink Health Systems, Inc. Announces Fiscal 2017 Second Quarter Resu...
ATLANTA--(BUSINESS WIRE)-- SunLink Health Systems, Inc. (NYSE MKT: SSY) today announced earnings from continuing operations of $2,949,000 or $0.31 per fully diluted share for its second fiscal quarter ended December 31, 2016 compared to a net loss of $8,566,000, or a loss of $0.91 per fully diluted share, for the quarter ended December 31, 2015. The earnings from continuing operations in the current fiscal year’s quarter are primarily due to the $2,819,000 gain on the previously announced sale of a medical office building complex in D...
SunLink Health Systems, Inc. Announces Extension of Tender Offer to Re...
ATLANTA--(BUSINESS WIRE)-- SunLink Health Systems, Inc. (NYSE MKT: SSY) announced today that it has extended its previously announced tender offer to purchase up to 3,000,000 of its common shares at a price of $1.50 per share (the “Offer”) until 5:00 p.m., New York City time, on Friday, February 24, 2017, unless further extended or terminated by SunLink. Tenders of shares must be made on or prior to the expiration of the Offer and may be withdrawn at any time on or prior to the expiration of the Offer. The tender offer to purchase com...
SunLink Health Systems, Inc. Announces Commencement of Tender Offer to...
ATLANTA--(BUSINESS WIRE)-- SunLink Health Systems, Inc. (NYSE MKT: SSY) announced today that it has commenced a tender offer to purchase up to 3,000,000 of its common shares at a price of $1.50 per share (the “Offer”). The number of shares proposed to be purchased in the Offer represents approximately 31.77% of the approximately 9,443,408 of SunLink’s outstanding common shares as of January 9, 2017 and involves an aggregate purchase price of $4,500,000. On January 5, 2017, the last full trading day prior to the announcement of the Off...
SunLink Health Systems, Inc. Announces Intention to Commence Tender Of...
ATLANTA--(BUSINESS WIRE)-- SunLink Health Systems, Inc. (NYSE MKT: SSY) announced today that it intends to commence a cash tender offer within the next week to purchase up to 3,000,000 of its common shares at a price per share of $1.50 per share. The number of shares proposed to be purchased in the tender offer represents approximately 31.8% of SunLink’s currently outstanding common shares and involves an aggregate purchase price of $4,500,000. The NYSE closing price of SunLink’s common shares on January 5, 2017 was $1.12 per share. ...
SunLink Health Systems’ Subsidiary Reaches Agreement to Sell Medical...
ATLANTA--(BUSINESS WIRE)-- SunLink Health Systems, Inc. (NYSE MKT: SSY) today announced that it sold its medical office building complex, comprised of land and three buildings in Ellijay, GA for $4,900,000. The company expects to recognize a pre-tax gain on the sale of the property of approximately $2,700,000 and a pre-tax loss on the early extinguishment of the property’s related debt of approximately $300,000 in its second fiscal quarter ending December 31, 2016. The company expects net proceeds from the sale of approximately $2,600...
SunLink Shareholders Approve Charter Amendments to Protect Tax Net Ope...
ATLANTA--(BUSINESS WIRE)-- SunLink Health Systems, Inc. (NYSE MKT: SSY) today announced that its shareholders approved, at its annual meeting on November 7, 2016, amendments to the company’s articles of incorporation to restrict certain transfers of common shares in order to protect the tax benefits of the company’s net operating losses (NOLs). The amendments generally void transfers of shares that would result in the creation of a new 4.9% shareholder or result in an existing 4.9% shareholder acquiring additional shares. The purpose ...
SunLink Health Systems, Inc. Announces Fiscal 2017 First Quarter Resul...
ATLANTA--(BUSINESS WIRE)-- SunLink Health Systems, Inc. (NYSE MKT: SSY) today announced net earnings of $3,023,000 or $0.32 per fully diluted share for its first fiscal quarter ended September 30, 2016 compared to a net loss of $1,668,000, or a loss of $0.18 per fully diluted share, for the quarter ended September 30, 2015. The net earnings in the current year’s quarter are due to the gain on the previously announced sale of a subsidiary hospital, Chestatee Regional Hospital in Dahlonega, GA. The company had a loss from continuing ope...
SunLink Health Systems’ Subsidiary Reaches Agreement to Sell Medical...
ATLANTA--(BUSINESS WIRE)-- SunLink Health Systems, Inc. (NYSE MKT: SSY) today announced that a subsidiary has reached agreement to sell its medical office building complex, comprised of land and three buildings in Ellijay, GA for approximately $4,900,000. The company expects to recognize a pre-tax gain on the sale of approximately $2,400,000. The transaction is subject to buyer due diligence and other conditions and is anticipated to close in December 2016. After repayment of mortgage debt and expenses of approximately $2,300,000, the...
SunLink Health Systems, Inc. Announces Fiscal 2016 Fourth Quarter and ...
ATLANTA--(BUSINESS WIRE)-- SunLink Health Systems, Inc. (NYSE MKT: SSY) today announced a loss from continuing operations for its fourth fiscal quarter ended June 30, 2016 of $823,000 or a loss of $0.09 per fully diluted share, compared to a loss from continuing operations of $7,000 or a loss of $0.00 per fully diluted share, for the quarter ended June 30, 2015. Net loss for the quarter ended June 30, 2016 was $1,234,000, or a loss of $0.13 per fully diluted share, compared to net earnings of $92,000, or $0.01 per fully diluted share,...
SunLink Adopts Shareholder Rights Plan to Protect Tax Benefits
ATLANTA--(BUSINESS WIRE)-- SunLink Health Systems, Inc. (NYSE MKT: SSY) (the “Company”) today announced that its Board of Directors has acted to protect the Company’s valuable income tax net operating loss carryforwards (“NOLs”) by adopting a new tax benefits protection rights plan. The purpose of the rights plan is to protect shareholder value by preserving the Company’s ability to use its NOLs in the future. The rights plan is similar to plans adopted by other public companies with significant net operating losses. As part of the ri...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.